(Q28250035)

English

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

scientific article

In more languages

Statements

scholarly article

0 references

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial (English)

0 references

phase III clinical trial

0 references

multicenter clinical trial

0 references

0 references

Trypanosoma brucei

0 references

trypanosomiasis

0 references

(RS)-eflornithine

0 references

Trypanosoma brucei gambiense infectious disease

0 references

17

0 references

Gerardo Priotto

1

object named as

Gerardo Priotto

0 references

author name string

Gerardo Priotto

1

0 references

Serena Kasparian

2

0 references

Wilfried Mutombo

3

0 references

Daniel Ngouama

4

0 references

Sara Ghorashian

5

0 references

Ute Arnold

6

0 references

Salah Ghabri

7

0 references

Elisabeth Baudin

8

0 references

Vincent Buard

9

0 references

Serge Kazadi-Kyanza

10

0 references

Médard Ilunga

11

0 references

Willy Mutangala

12

0 references

Gabriele Pohlig

13

0 references

Caecilia Schmid

14

0 references

Unni Karunakara

15

0 references

Els Torreele

16

0 references

language of work or name

0 references

publication date

4 July 2009

0 references

0 references

374

0 references

56-64

0 references

9683

0 references

Eliminating human African trypanosomiasis: where do we stand and what comes next?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The situation of sleeping sickness in Angola: a calamity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospects for improving African trypanosomiasis chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Polyamine metabolism: a potential therapeutic target in trypanosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo effects of alpha-DL-difluoromethylornithine on the metabolism and morphology of Trypanosoma brucei brucei.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial and pharmacokinetic study of intravenous and oral alpha-difluoromethylornithine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case series

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of the acridine orange QBC technique in the diagnosis of African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

"Proving the null hypothesis" in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha-difluoromethylornithine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961117-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(09)61117-X

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28250035&oldid=1398133113"